Search:
   

Friday, February 24, 2017

Equity Trader Alert #2017 - 37
Information Regarding the Merger of Integra LifeSciences Holding Corporation and Derma Sciences, Inc. (DSCI)

Category:

  • Listing

Markets Impacted:

Contact Information:

Resources

(UPDATED) The merger of Derma Sciences, Inc. (DSCI) with and into Integra Derma, Inc., a wholly-owned subsidiary of Integra LifeSciences Holding Corporation has become effective. The details are as follows:

Company: Derma Sciences, Inc.
Issue: Common Stock
CUSIP#: 249827502
Symbol: DSCI
Marketplace Effective Date for Suspension: February 27, 2017
Merger Consideration: $7.00 per share.

Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives. To unsubscribe, also click on the enrollment form

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile